An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma

An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma

Abstract Background Diffuse large B-cell lymphoma (DLBCL) is one of the most aggressive malignant tumors. Chromobox (CBX) family plays the role of oncogenes in various malignancies. Methods The transcriptional and protein levels of CBX family were confirmed by GEPIA, Oncomine, CCLE, and HPA database...

Full description

Bibliographic Details
Main Authors:	Fenling Zhou, Lu Chen, Peng Lu, Yuli Cao, Cuilan Deng, Gexiu Liu
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Series:	BMC Cancer
Subjects:	DLBCL Chromobox family Bioinformatics analysis Biomarker
Online Access:	https://doi.org/10.1186/s12885-023-11108-6

Similar Items

Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation
by: Tian H, et al.
Published: (2022-12-01)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
by: Xuefen Fang, et al.
Published: (2022-04-01)

Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer
by: Dan Liao, et al.
Published: (2023-04-01)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
by: Yuanyuan Zhu, et al.
Published: (2021-07-01)

Integrated bioinformatics investigation and experimental validation reveals the clinical and biological significance of chromobox family in breast cancer
by: Xin Ge, et al.
Published: (2025-02-01)

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
by: Chenxi Pan, et al.
Published: (2022-05-01)

Diverse CBX family members as potential prognostic biomarkers in non‐small‐cell lung cancer
by: Xiaobin Xie, et al.
Published: (2020-10-01)

Unveiling CKS2: A Key Player in Aggressive B‐Cell Lymphoma Progression and a Target for Synergistic Therapy
by: Fenling Zhou, et al.
Published: (2024-11-01)

Chromobox 7/8 serve as independent indicators for glioblastoma via promoting proliferation and invasion of glioma cells
by: Zong-Qing Zheng, et al.
Published: (2022-08-01)

Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use
by: Qingyuan Qu, et al.
Published: (2019-11-01)

Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
by: Tian Ping, et al.
Published: (2021-03-01)

Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation
by: Bo Chen, et al.
Published: (2022-11-01)

RETRACTED ARTICLE: Correlations between chromobox homolog 8 and key factors of epithelial–mesenchymal transition in hepatocellular carcinoma
by: Xiaonian Zhu, et al.
Published: (2019-12-01)

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
by: Johanna Vets, et al.
Published: (2023-04-01)

Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia
by: Haoyue Liang, et al.
Published: (2025-02-01)

Chromobox homolog 4 overexpression inhibits TNF-α-induced matrix catabolism and senescence by suppressing activation of NF-κB signaling pathway in nucleus pulposus cells
by: Zhang Yangyang, et al.
Published: (2022-06-01)

Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma
by: Changying Wang, et al.
Published: (2023-03-01)

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
by: Wei Zhang, et al.
Published: (2020-07-01)

The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses
by: Yi Pan, et al.
Published: (2021-11-01)

DIFFUSE LARGE B-CELL LYMPHOMA OF THE HEART
by: Faizah Dwi Tirtasari, et al.
Published: (2022-05-01)

Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma
by: Simon Le Gallou, et al.
Published: (2021-12-01)

Primary diffuse large B-cell lymphoma at gastrojejunostomy site: A rare case report
by: Shruthi, et al.
Published: (2023-01-01)

BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA
by: Christian Gisselbrecht, et al.
Published: (2016-07-01)

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma
by: Epameinondas Koumpis, et al.
Published: (2024-11-01)

The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS
by: Ji-Wei Li, et al.
Published: (2024-01-01)

Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications
by: Epameinondas Koumpis, et al.
Published: (2024-07-01)

Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer
by: Xinxin Li, et al.
Published: (2023-04-01)

Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
by: Smeeta Gejendra, et al.
Published: (2015-11-01)

Unusual Alveolar Pattern in Node Based Diffuse Large B-cell Lymphoma
by: Archana C. Buch, et al.
Published: (2017-01-01)

Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
by: Aya Nakaya, et al.
Published: (2016-01-01)

Recurrent fibrin associated diffuse large B-cell lymphoma: A case report
by: Mohebnasab Maedeh, et al.
Published: (2021-09-01)

Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma
by: Kasper Thystrup Karstensen, et al.
Published: (2020-12-01)

Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
by: Gohar S. Manzar, et al.
Published: (2024-09-01)

IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication
by: Xuemei Wu, et al.
Published: (2023-05-01)

Localised gastrointestinal diffuse large B cell lymphomas; Does surgical approach still exist?
by: Ibrahim Abeer, et al.
Published: (2015-03-01)

GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration
by: Can Chen, et al.
Published: (2024-02-01)

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma
by: Jie Wang, et al.
Published: (2020-12-01)

Frequency and clinical association of NY-ESO-1 gene expression in diffuse large B-cell lymphoma
by: Irma Olarte-Carrillo, et al.
Published: (2022-10-01)

CD30 Expression and Its Correlation with Clinicopathologic Features in Indonesian Diffuse Large B-Cell Lymphoma
by: Maria Reynelda Santoso, et al.
Published: (2020-09-01)

Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses
by: He Zhou, et al.
Published: (2021-07-01)